Insights

Over 400 attendees from the buy and sell side joined us in person in New York in June 2022 to debate how the American research market has re-emerged from lockdown protocols, and the implications for research budgeting and valuation from investment professionals’ increasingly data-driven focuses. On November 9th we will reunite the global investment research industry at the Institute of Directors in London to discuss the key issues affecting the external research and data markets, and how research providers are being valued and rewarded in a volatile market climate.

Regulatory issues are back with a vengeance – the SEC’s announcement that it would not be extending the no action relief covering research payments has implications for any firm with a European entity that is consuming US broker research. All the potential solutions have structural challenges and none of them are achievable before the no action expires in July 2023.

Panels will also cover how buy side approaches to research budgeting, valuation and consumption are evolving, how corporate access now works post-lockdowns and what’s changed most, and how the greater focus on ESG and alt data works from a research and data budgeting and valuation perspective. Attendance for confirmed buyside delegates is complimentary, and there are also a limited number of complimentary sellside places.

Panels will include:

1. Regulatory Developments and their Implications for Research – the SEC removal of the No Action Relief, plus ESG and crypto regulatory impact on research and data markets

2. Research & Data Budgeting and Valuation – how the buy side is allocating research and data payments and how their process has evolved

3. The Research Product – how the sell side and independent providers are changing their products and services, and how they ensure their investments into new areas are appropriately rewarded by clients

4. ESG Research & Data – demand from the buy side, mapping the supply from pure data providers as well as the sell side’s strategy in this market

5. Corporate Access – How corporate access works in a virtual/physical hybrid world, and how the role of investor, corporate and sell side facilitator has changed

6. Integration of Research & Data – Portfolio managers are increasingly data-driven and this has implications for sourcing, budgeting and payment structures – what does best practice look like?

Speakers from 2021 included:

Alex Andronov, Global Head of Business Development, Global Research, HSBC
Félix-A. Boudreault, Managing Partner, Sustainable Market Strategies
Alex Coffey, Head of EMEA Research, Jefferies
Marie-José Freier, Head of Cross Asset ESG Research, Barclays
Jason Glazer, Head of Product Management, Piper Sandler
James Nadin, Research Manager, Artemis
Oliver Pratley, Research Relationship Manager, Invesco
Hugo Sanders, Director of Corporate Access & Research, Wellington Management
Puja Schams, Lombard Odier Investment Managers
Rudolf Siebel, Managing Director, German Investment Funds Association (BVI)
Terence Sinclair, Global Franchise Director, Citi Research
Karen Zachery, CEO, Crux Asset Management